A recent article from The Guardian discussed a new blood test that screens for hard-to-detect cancers. The system, developed at Harvard Medical School’s Dana-Farber Cancer Institute, not only detects cancer, but also uses machine learning to indicate what type of cancer the patient has. The team behind the concept gave the system data related to methylation patterns in DNA from blood samples of over 2,800 patients. Roughly half of the sample group had cancer, while the other half did not.
Quick Hits: 50-in-1 Blood Test Detects Cancer Early
Researchers at Harvard Medical School have developed a new blood test that detects cancerous tumor DNA.
Apr 2, 2020
Recommended
Recommended
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
